Israel Englander Neurocrine Biosciences Inc Call Options Transaction History

Millennium Management LLC

  • $175 Billion
  • Q1 2025

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2025

May 15, 2025
BUY
$107.22 - $153.29 $4.24 Million - $6.05 Million
39,500 Added 556.34%
46,600 $5.15 Million
Q4 2024

Feb 14, 2025
BUY
$111.62 - $139.44 $792,502 - $990,024
7,100 New
7,100 $969,000
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $14.1 Million - $15.4 Million
107,500 New
107,500 $14.8 Million

Others Institutions Holding NBIX

# of Institutions
650
Shares Held
97.2M
Call Options Held
749K
Put Options Held
553K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email